Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
CagriSema is an investigational combination therapy that merges cagrilintide, an amylin analogue, with semaglutide, a GLP-1 receptor agonist, to provide a dual-acting treatment approach for obesity and type 2 diabetes. The formulation targets both appetite suppression and improved glycemic control, offering a promising solution for individuals struggling with weight-related metabolic conditions. As demand grows to buy CagriSema, healthcare professionals emphasize its potential role in comprehensive, medically supervised weight management programs.
| Fact Table | |
|---|---|
| Formula | Cagrilintide: C273H420N74O81S1; Semaglutide: C187H291N45O59 |
| License | Investigational (Phase 3) |
| Bioavailability | Subcutaneous: Moderate (semaglutide ~89%) |
| Legal status | Not yet approved |
| Chemical Name | Cagrilintide and Semaglutide (synthetic peptides) |
| Elimination half-life | Cagrilintide: ~8 days; Semaglutide: ~7 days |
| Dosage (Strength) | Investigational doses (e.g., Cagrilintide 2.4 mg + Semaglutide 2.4 mg weekly) |
| Pregnancy | Not established; consult healthcare provider |
| Brands | CagriSema (developmental) |
| Protein binding | Semaglutide: >99%; Cagrilintide: Not well documented |
| PubChem CID | Semaglutide: 56843331; Cagrilintide: Not listed |
| MedlinePlus | Not assigned |
| ChEBI | Semaglutide: 145346; Cagrilintide: Not available |
| ATC code | Not yet assigned |
| DrugBank | Semaglutide: DB13928; Cagrilintide: Not listed |
| KEGG | Semaglutide: D10590; Cagrilintide: Not listed |
| Routes of administration | Subcutaneous injection (once weekly) |
CagriSema is designed for subcutaneous injection once weekly, with a gradual dose escalation to reduce gastrointestinal discomfort and improve adherence. Patients beginning treatment should be counseled on proper injection technique and the importance of routine monitoring. For individuals pursuing CagriSema for weight loss, consistent dietary changes and physical activity remain crucial adjuncts to pharmacologic therapy.
Each dose of CagriSema contains two active ingredients:
Clinical use of CagriSema requires careful evaluation in patients with pancreatitis history, gallbladder issues, or kidney impairment. The cost of CagriSema may differ depending on region and insurance coverage, and patients should verify pricing options with pharmacies or prescribing clinics. It should not be combined with other GLP-1 receptor agonists or similar agents.
CagriSema should not be used in patients with a personal or familial history of medullary thyroid carcinoma or those diagnosed with MEN 2 syndrome. Hypersensitivity to either cagrilintide, semaglutide, or formulation excipients also contraindicates its use. Physicians should assess individual risk factors before prescribing.
Potential side effects include:
Severe but uncommon adverse reactions, such as pancreatitis or thyroid-related concerns, necessitate prompt medical attention.
What is CagriSema?
CagriSema is a combination medication containing cagrilintide and semaglutide, designed for weight management and metabolic health improvement.
How does CagriSema work?
CagriSema works through dual mechanisms: semaglutide mimics GLP-1 to regulate appetite and slow gastric emptying, while cagrilintide acts as an amylin analog to enhance satiety and complement the effects of semaglutide.
How is CagriSema administered?
CagriSema is administered as a once-weekly subcutaneous injection using a pre-filled pen device.
What kind of weight loss results can I expect with CagriSema?
Clinical trials have shown that patients using CagriSema may experience significant weight loss, potentially greater than with either medication alone, with many patients losing 15-20% of their initial body weight.
What are the most common side effects of CagriSema?
Common side effects include nausea, vomiting, diarrhea, constipation, and injection site reactions. These typically decrease in intensity over time as your body adjusts to the medication.
Is CagriSema suitable for patients with diabetes?
CagriSema may be suitable for patients with type 2 diabetes, as both components can help improve glycemic control. However, dosing may need to be adjusted, and close monitoring by a healthcare provider is essential.
How long does it take to see results with CagriSema?
Most patients begin to notice weight loss within the first 4-8 weeks of treatment, with maximum effects typically observed after 6-12 months of consistent use.
Can I stop taking CagriSema once I reach my target weight?
CagriSema is generally considered a long-term treatment. Discontinuing the medication often results in weight regain, so any decision to stop should be discussed with your healthcare provider.
Do I need to follow a specific diet while taking CagriSema?
While CagriSema can help reduce appetite, it works best when combined with a healthy, balanced diet and regular physical activity as recommended by your healthcare provider.
Can CagriSema interact with other medications?
CagriSema may interact with certain medications, particularly those that affect blood sugar or are absorbed in the gastrointestinal tract. Always inform your healthcare provider about all medications you're taking.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews